Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125691231 | 12569123 | 1 | I | 20160416 | 20160421 | 20160719 | 20160719 | PER | US-ASTRAZENECA-2016SE45003 | ASTRAZENECA | 15378.00 | DY | F | Y | 97.50000 | KG | 20160719 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125691231 | 12569123 | 1 | PS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | 204760 | 25 | MG | TABLET | QD | |||||||
| 125691231 | 12569123 | 2 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | RESTARTED THE MOVANTIK ON 19-APR-2016 AND TOOK THIS ON 20 AND 21-APR-2016 25 MG DAILY | 204760 | TABLET | |||||||||
| 125691231 | 12569123 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125691231 | 12569123 | 4 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125691231 | 12569123 | 5 | C | BUPROPION HCL | BUPROPION HYDROCHLORIDE | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 125691231 | 12569123 | 6 | C | AMITIZA | LUBIPROSTONE | 1 | Oral | 0 | 24 | UG | BID | ||||||||
| 125691231 | 12569123 | 7 | C | ONDANSETRON HCL | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4.0MG AS REQUIRED | 0 | 4 | MG | ||||||||
| 125691231 | 12569123 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 125691231 | 12569123 | 9 | C | DRONABINOL. | DRONABINOL | 1 | Oral | 0 | 5 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125691231 | 12569123 | 1 | Constipation |
| 125691231 | 12569123 | 2 | Constipation |
| 125691231 | 12569123 | 3 | Gastric disorder |
| 125691231 | 12569123 | 4 | Psychotherapy |
| 125691231 | 12569123 | 5 | Psychotic disorder |
| 125691231 | 12569123 | 6 | Constipation |
| 125691231 | 12569123 | 7 | Nausea |
| 125691231 | 12569123 | 8 | Abdominal distension |
| 125691231 | 12569123 | 9 | Nausea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125691231 | 12569123 | Abdominal pain | |
| 125691231 | 12569123 | Abdominal pain upper | |
| 125691231 | 12569123 | Bowel movement irregularity | |
| 125691231 | 12569123 | Drug dose omission | |
| 125691231 | 12569123 | Nausea | |
| 125691231 | 12569123 | Pain | |
| 125691231 | 12569123 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125691231 | 12569123 | 1 | 20160415 | 0 | ||
| 125691231 | 12569123 | 6 | 20160414 | 0 |